StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4
Publishing Date
2024 - 04 - 09
11
2024 - 04 - 08
15
2024 - 04 - 05
5
2024 - 03 - 06
7
2024 - 03 - 05
15
2023 - 11 - 06
6
2023 - 11 - 03
11
2023 - 10 - 31
5
2023 - 10 - 16
11
2023 - 10 - 04
8
2023 - 04 - 19
10
2023 - 04 - 18
13
2023 - 04 - 17
16
2023 - 03 - 14
13
2022 - 11 - 10
10
2022 - 11 - 07
5
2022 - 11 - 03
7
2022 - 10 - 26
5
2022 - 10 - 05
6
2022 - 06 - 10
7
2022 - 05 - 19
8
2022 - 05 - 16
6
2022 - 05 - 03
5
2022 - 04 - 25
5
2022 - 04 - 12
6
2022 - 04 - 11
8
2022 - 04 - 08
23
2022 - 03 - 09
5
2022 - 03 - 08
20
2021 - 12 - 14
5
2021 - 12 - 13
8
2021 - 11 - 12
12
2021 - 11 - 11
4
2021 - 11 - 09
4
2021 - 11 - 04
9
2021 - 10 - 25
4
2021 - 10 - 21
4
2021 - 10 - 20
4
2021 - 10 - 19
4
2021 - 10 - 12
5
2021 - 10 - 07
12
2021 - 10 - 05
4
2021 - 10 - 01
8
2021 - 09 - 30
9
2021 - 09 - 23
4
2021 - 07 - 12
4
2021 - 06 - 21
4
2021 - 06 - 03
4
2021 - 05 - 12
5
2021 - 05 - 11
7
2021 - 05 - 10
5
2021 - 04 - 28
5
2021 - 04 - 27
5
2021 - 04 - 12
11
2021 - 04 - 10
18
2021 - 04 - 09
5
2021 - 03 - 11
5
2021 - 03 - 10
6
2021 - 02 - 08
4
2020 - 12 - 07
5
Sector
Health technology
1
Professional, scientific, and technical services
1
Tags
5g
3
Acquisition
6
America
3
Awards
4
Biotech-bay
7
Biotech-beach
5
Cloud
4
Conference
50
Contract
6
Corporation
18
Deadline
18
Designation
4
Diagnostic
4
Diagnostics
4
Disease
5
Distribution
5
Drug
3
Earnings
15
Energy
14
Europe
3
Events
5
Fda
3
Food
5
Genetown
4
Group
5
Growth
24
Health
6
Home
3
Innovation
3
Insurance
3
International
4
Internet
3
Laser
3
Management
7
Market
45
Money
3
N/a
436
Offering
10
Partnership
5
People
7
Pharma
4
Phase 2b
4
Platform
6
Pre-clinical
4
Preclinical
4
Program
7
Report
40
Repurchase
4
Research
17
Results
84
Sales
8
Service
4
Services
9
Solutions
8
System
6
Technology
9
Test
4
Therapeutics
19
Treatment
6
Trial
5
Entities
Algernon pharmaceuticals inc.
1
Janux therapeutics inc
1
Neximmune inc
1
Virpax pharmaceuticals inc
1
Symbols
AGNPF
1
JANX
1
NEXI
1
VRPX
1
Exchanges
Nasdaq
4
Crawled Date
2022 - 04 - 26
4
Crawled Time
13:00
2
13:20
2
Source
www.biospace.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2022 - 04 - 26
tags :
Preclinical
save search
Virpax Successfully Completes Initial Preclinical Studies for VRP324
Published:
2022-04-26
(Crawled : 13:20)
- biospace.com/
VRPX
|
$3.86
-4.46%
-4.66%
6K
|
|
97.16%
|
O:
5.11%
H:
2.7%
C:
-5.41%
vrp324
preclinical
virpax
pre-clinical
Janux Therapeutics to Present Preclinical Data at the 18th Annual PEGS Boston for PSMA-TRACTr and EGFR-TRACTr
Published:
2022-04-26
(Crawled : 13:20)
- biospace.com/
JANX
|
$48.69
-0.33%
-0.33%
670K
|
Professional, Scientific, and T...
|
263.88%
|
O:
-1.97%
H:
1.39%
C:
-2.17%
preclinical
therapeutics
pre-clinical
Algernon Pharmaceuticals Announces Lead Chronic Kidney Disease Drug Repirinast Reduced Fibrosis by 56% in a Preclinical NASH Study
Published:
2022-04-26
(Crawled : 13:00)
- biospace.com/
AGNPF
|
$0.0708
178.69%
1.3K
|
Health Technology
|
-98.51%
|
O:
-8.89%
H:
0.0%
C:
0.0%
fibrosis
drug
disease
preclinical
kidney
nash
pre-clinical
NexImmune Announces Preclinical Research Collaboration with Columbia University Irving Medical Center’s Herbert Irving Comprehensive Cancer Center
Published:
2022-04-26
(Crawled : 13:00)
- biospace.com/
NEXI
|
$3.22
-2.42%
-2.48%
23K
|
|
23.05%
|
O:
1.56%
H:
6.6%
C:
-16.15%
research
preclinical
collaboration
cancer
pre-clinical
Gainers vs Losers
69%
31%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
KNW
4
|
$0.59
-0.71%
18.64%
27K
|
Manufacturing
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
News
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.